Technology Development for the Synthesis of S-Amlodipine Nicotinate Drug Substance


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Technology for the synthesis of S-amlodipine nicotinate drug substance was developed based on an acceptable method of effective separation of the amlodipine optical isomers. A literature review suggested that the most promising methods employed 2-propanol (pure or with small additions of cosolvents) as the main solvent. However, experiments showed that the optimum solvent was DMSO. The proposed synthesis of S-amlodipine nicotinate drug substance was confirmed to be stable and reproducible. Standardization methods were developed.

About the authors

G. A. Kim

All-Russia Scientific Center for Safety Testing of Biologically Active Substances, Ministry of Public Health of the Russian Federation

Email: chem@folium.ru
Russian Federation, 23 Kirova St., Staraya Kupavna, Moscow Oblast, 142450

Zh. M. Kozlova

I. M. Sechenov First Moscow State Medical University

Email: chem@folium.ru
Russian Federation, 2/4 Bol’shaya Pirogovskaya St., Moscow, 119991

S. O. Pchelintsev

I. M. Sechenov First Moscow State Medical University

Email: chem@folium.ru
Russian Federation, 2/4 Bol’shaya Pirogovskaya St., Moscow, 119991

R. T. Savel’yanova

EcoChem-Innovations

Email: chem@folium.ru
Russian Federation, 8 Druzhby St., Novomoskovsk, Tula Oblast, 301650

N. M. Berezina

EcoChem-Innovations

Email: chem@folium.ru
Russian Federation, 8 Druzhby St., Novomoskovsk, Tula Oblast, 301650

I. I. Krasnyuk

I. M. Sechenov First Moscow State Medical University

Email: chem@folium.ru
Russian Federation, 2/4 Bol’shaya Pirogovskaya St., Moscow, 119991


Copyright (c) 2017 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies